{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:47:05Z","timestamp":1786546025652,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1038\/s41395-018-0247-9","type":"journal-article","created":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T05:13:13Z","timestamp":1539321193000},"page":"1629-1638","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["On-Treatment Improvement of MELD Score Reduces Death and Hepatic Events in Patients With Hepatitis B-Related Cirrhosis"],"prefix":"10.14309","volume":"113","author":[{"given":"Terry Cheuk-Fung","family":"Yip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry Lik-Yuen","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee-Kit","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin Long-Yan","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Chung-Yan","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Wai-Sun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace Lai-Hung","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-18-20210302","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1053\/he.2000.5852","article-title":"A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.","volume":"31","author":"Malinchoc","year":"2000","journal-title":"Hepatology"},{"key":"R2-18-20210302","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease.","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"R3-18-20210302","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jhep.2004.12.022","article-title":"MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis.","volume":"42","author":"Srikureja","year":"2005","journal-title":"J Hepatol"},{"key":"R4-18-20210302","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jhep.2005.01.021","article-title":"MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices.","volume":"42","author":"Amitrano","year":"2005","journal-title":"J Hepatol"},{"key":"R5-18-20210302","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1111\/j.1572-0241.2007.01485.x","article-title":"Association between model for end-stage liver disease and spontaneous bacterial peritonitis.","volume":"102","author":"Obstein","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R6-18-20210302","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation.","volume":"41","author":"Alessandria","year":"2005","journal-title":"Hepatology"},{"key":"R7-18-20210302","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1053\/j.gastro.2007.01.040","article-title":"Risk factors for mortality after surgery in patients with cirrhosis.","volume":"132","author":"Teh","year":"2007","journal-title":"Gastroenterology"},{"key":"R8-18-20210302","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list.","volume":"359","author":"Kim","year":"2008","journal-title":"N Engl J Med"},{"key":"R9-18-20210302","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1586\/17474124.2014.909724","article-title":"Current developments in nucleosidenucleotide analogues for hepatitis B.","volume":"8","author":"Lo","year":"2014","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R10-18-20210302","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hep.26301","article-title":"Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis.","volume":"58","author":"Wong","year":"2013","journal-title":"Hepatology"},{"key":"R11-18-20210302","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1053\/j.gastro.2013.02.002","article-title":"Accuracy of risk scores for patients with chronic hepatitis B receiving entecavir treatment.","volume":"144","author":"Wong","year":"2013","journal-title":"Gastroenterology"},{"key":"R12-18-20210302","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B.","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"key":"R13-18-20210302","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"Electronic address eee, European Association for the Study of the L. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"R14-18-20210302","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"key":"R15-18-20210302","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1053\/jhep.2001.26512","article-title":"Lamivudine treatment is beneficial in patients with severely decompensated cirrhosis and actively replicating hepatitis B infection awaiting liver transplantation: a comparative study using a matched, untreated cohort.","volume":"34","author":"Yao","year":"2001","journal-title":"Hepatology"},{"key":"R16-18-20210302","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3748\/wjg.v22.i4.1570","article-title":"Liver transplantation for viral hepatitis in 2015.","volume":"22","author":"Ferrarese","year":"2016","journal-title":"World J Gastroenterol"},{"key":"R17-18-20210302","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000445152","article-title":"Pre- and post-transplant antiviral therapy (HBV, HCV).","volume":"32","author":"Welker","year":"2016","journal-title":"Visc Med"},{"key":"R18-18-20210302","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jhep.2005.01.019","article-title":"Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.","volume":"42","author":"Huo","year":"2005","journal-title":"J Hepatol"},{"key":"R19-18-20210302","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/jlts.2003.50009","article-title":"Longitudinal assessment of mortality risk among candidates for liver transplantation.","volume":"9","author":"Merion","year":"2003","journal-title":"Liver Transpl"},{"key":"R21-18-20210302","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jhep.2017.06.019","article-title":"Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance.","volume":"67","author":"Yip","year":"2017","journal-title":"J Hepatol"},{"key":"R22-18-20210302","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers.","volume":"124","author":"Wiesner","year":"2003","journal-title":"Gastroenterology"},{"key":"R24-18-20210302","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/lt.24085","article-title":"Use of serum sodium for liver transplant graft allocation: a decade in the making, now is it ready for primetime?","volume":"21","author":"Biggins","year":"2015","journal-title":"Liver Transpl"},{"key":"R25-18-20210302","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/apt.14341","article-title":"Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis.","volume":"46","author":"Wong","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"R26-18-20210302","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"key":"R27-18-20210302","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"R28-18-20210302","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"R29-18-20210302","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2012.02.033","article-title":"Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy.","volume":"57","author":"Peng","year":"2012","journal-title":"J Hepatol"},{"key":"R30-18-20210302","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-6143.2004.00703.x","article-title":"The survival benefit of liver transplantation.","volume":"5","author":"Merion","year":"2005","journal-title":"Am J Transplant"},{"key":"R31-18-20210302","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jhep.2010.02.035","article-title":"Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.","volume":"53","author":"Papatheodoridis","year":"2010","journal-title":"J Hepatol"},{"key":"R32-18-20210302","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/apt.12207","article-title":"Meta-analysis: The association of hepatitis B virus genotypes and hepatocellular carcinoma.","volume":"37","author":"Wong","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R33-18-20210302","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1136\/gut.2003.033324","article-title":"Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.","volume":"53","author":"Chan","year":"2004","journal-title":"Gut"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41395-018-0247-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41395-018-0247-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ovid.com\/00000434-201811000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/s41395-018-0247-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:50:25Z","timestamp":1786542625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201811000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1038\/s41395-018-0247-9","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}